REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $141,023 | +5.0% | 5,094,706 | +1.5% | 0.02% | +10.5% |
| Q2 2023 | $134,253 | +23.1% | 5,018,765 | -0.3% | 0.02% | +18.8% |
| Q1 2023 | $109,063 | +24.4% | 5,035,179 | +36.8% | 0.02% | +14.3% |
| Q4 2022 | $87,659 | -99.9% | 3,680,042 | +0.8% | 0.01% | +16.7% |
| Q3 2022 | $72,030,000 | +65.1% | 3,652,628 | +63.2% | 0.01% | +100.0% |
| Q2 2022 | $43,616,000 | -25.7% | 2,237,854 | -2.7% | 0.01% | 0.0% |
| Q1 2022 | $58,668,000 | +120.8% | 2,299,816 | +117.8% | 0.01% | +200.0% |
| Q4 2021 | $26,574,000 | -5.3% | 1,055,771 | +3.5% | 0.00% | -33.3% |
| Q3 2021 | $28,056,000 | +4830.8% | 1,019,846 | +5589.8% | 0.00% | – |
| Q2 2021 | $569,000 | -21.8% | 17,924 | +12.9% | 0.00% | – |
| Q1 2021 | $728,000 | -80.2% | 15,875 | -82.9% | 0.00% | – |
| Q4 2020 | $3,675,000 | -12.7% | 92,820 | -30.4% | 0.00% | -100.0% |
| Q2 2020 | $4,211,000 | +101.4% | 133,371 | +39.8% | 0.00% | – |
| Q1 2020 | $2,091,000 | – | 95,432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |